Comparison of Clinical Characteristics and Comorbidity in Schizophrenia Patients with and without Obsessive-Compulsive Disorder: Schizophrenic and OC Symptoms in Schizophrenia

Journal of Clinical Psychiatry

Volumn 64, Issue 11, 2003, Pages 1300-1307

  Poyurovsky, Michael ^a,b   Kriss, Victoria ^a   Weisman, Gregory ^a   Faragian, Sarit ^a   Kurs, Rena ^c   Schneidman, Michael ^a   Fuchs, Camil ^c   Weizman, Abraham ^c,e   Weizman, Ronit ^c,d  

^a Technion Medical School   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d SHALVATA MENTAL HEALTH CENTER   (Israel)

^e GEHA MENTAL HEALTH CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CLOMIPRAMINE; CLOZAPINE; FLUOXETINE; FLUVOXAMINE; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGE; ARTICLE; BODY DYSMORPHIC DISORDER; CLINICAL FEATURE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HAMILTON SCALE; HOSPITALIZATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; OBSESSIVE COMPULSIVE DISORDER; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGIC ASSESSMENT; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; SCORING SYSTEM; TIC; VALIDATION PROCESS;

EID: 0344119582     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v64n1104     Document Type: Article

References (39)

1. Bermanzohn PC, Porto L, Arlow PB, et al. Hierarchical diagnosis in chronic schizophrenia: a clinical study of co-occuring syndromes. Schizophr Bull 2002;26:517-525
2. Fenton WS, McGlashan TH. The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry 1986;143:437-441
3. Eisen JL, Beer DA, Pato MT, et al. Obsessive-compulsive disorder in patients with schizophrenia and schizoaffective disorder. Am J Psychiatry 1997;154:271-273
4. Porto L, Bermanzohn PC, Pollack S, et al. A profile of obsessive-compulsive symptoms in schizophrenia. CNS Spectr 1997;2:21-25
5. Poyurovsky M, Fuchs K, Weizman A. Obsessive-compulsive symptoms in patients with first episode schizophrenia. Am J Psychiatry 1999;156:1998-2000
6. Poyurovsky M, Hromnikov S, Isakov V, et al. Obsessive-compulsive disorder in chronic institutionalized schizophrenic patients. Psychiatry Res 2001;102:49-57
7. Foa EB, Kozak MJ. DSM-IV field trial: obsessive-compulsive disorder. Am J Psychiatry 1995;152:90-96
8. Berman I, Kalinowski A, Berman S, et al. Obsessive-compulsive symptoms in chronic schizophrenia. Compr Psychiatry 1995;36:6-10
9. Hwang MY, Morgan JE, Losconzcy MF. Clinical and neuropsychological profiles of obsessive-compulsive schizophrenia: a pilot study. J Neuropsychiatry Clin Neurosci 2000;12:91-104
10. Berman I, Merson A, Viegner B, et al. Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological study. J Nerv Ment Dis 1998;186:150-156
11. Poyurovsky M, Isakov V, Hromnikov S, et al. Fluvoxamine treatment of obsessive-compulsive symptoms in schizophrenic patients: an add-on open study. Int Clin Psychopharmacol 1999;14:95-100
12. Zohar J, Kaplan Z, Benjamin J. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients. J Clin Psychiatry 1993;54:385-388
13. Berman I, Sapers BL, Chang HHJ, et al. Treatment of obsessive-compulsive symptoms in schizophrenic patients with clomipramine. J Clin Psychopharmacol 1995;15:206-210
14. Bermanzohn PC, Porto L, Arlow PB, et al. Are some neuroleptic-refractory symptoms of schizophrenia really obsessions? CNS Spectr 1997;2:51-57
15. Kruger S, Braunig P, Hoffler J, et al. Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms. J Neuropsychiatry Clin Neurosci 2000;12:16-24
16. Lysaker PH, Marks KA, Picone JB, et al. Obsessive and compulsive symptoms in schizophrenia: clinical and neurocognitive correlates. J Nerv Ment Dis 2000;188:78-83
17. Tibbo P, Kroetsch M, Chue P, et al. Obsessive-compulsive disorder in schizophrenia. J Psychiatr Res 2000;34:139-146
18. Hollander E, Wong CM. Introduction: obsessive-compulsive spectrum disorders. J Clin Psychiatry 1995;56(suppl 4):3-6; discussion 53-55
19. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P, version 2.0). New York, NY: Biometric Research, New York State Psychiatric Institute; 1995
20. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive-Compulsive Scale, 1: development, use. and reliability. Arch Gen Psychiatry 1989:46:1006-1011
21. Andreasen NC. The Scale for the Assessment of Positive Symptoms in Schizophrenia. Iowa City, Ia: University of Iowa; 1984
22. Andreasen NC. The Scale for the Assessment of Negative Symptoms in Schizophrenia. Iowa City, Ia: University of Iowa; 1983
23. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:534-537
24. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
25. Simpson GM, Angus JWS. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 1970;212(suppl):11-19
26. World Health Organization Collaborating Center for Drug Statistics. Guidelines for ATC Classification and DDD Assignment. Oslo, Norway: WHO Collaborating Center for Drug Statistics; 2000
27. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B 1995;57:289-300
28. Eisen JL, Rasmussen SA. Obsessive compulsive disorder with psychotic features. J Clin Psychiatry 1993;54:373-379
29. Matsunaga H, Kiriike N, Matsui T, et al. Obsessive-compulsive disorder with poor insight. Compr Psychiatry 2002;43:150-157
30. Gordon A. Transition of obsessions into delusions. Am J Psychiatry 1950;107:455-458
31. Insel TR, Akiskal HS. OCD with psychotic features: a phenomenological analysis. Am J Psychiatry 1986;143:1527-1533
32. Kendler K, Glazer WM, Morgenstern H. Dimensions of delusional experience. Am J Psychiatry 1983;140:466-469
33. Appelbaum PS, Robbins PC, Roth LH. Dimensional approach to delusions: comparison across types and diagnoses. Am J Psychiatry 1999;156:1938-1943
34. Spitzer M. On defining delusions. Compr Psychiatry 1990;31:377-397
35. Tamminga CA, Buchanan RW, Gold JM. The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. Int Clin Psychopharmacol 1998;13(suppl 3):S21-S26
36. Strakowski SM, Tohen M, Stoll AL, et al. Co-morbidity in psychosis at first hospitalization. Am J Psychiatry 1993;150:752-757
37. Allen A, Hollander A. Body dysmorphic disorder. Psychiatr Clin North Am 2000;23:617-628
38. Poyurovsky M, Hermesh H, Weizman A. Fluvoxamine treatment in clozapine-induced obsessive-compulsive symptoms in schizophrenia symptoms. Clin Neuropharmacol 1996;19:305-313
39. Poyurovsky M, Dorfman-Etrog P, Hermesh H, et al. Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms. Int Clin Psychopharmacol 2000;15:169-173